Live Breaking News & Updates on Blu santanders

Stay informed with the latest breaking news from Blu santanders on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Blu santanders and stay connected to the pulse of your community

Coretronic Intelligent Robotics sees growing drone shipments

Coretronic Intelligent Robotics (CIRC), a subsidiary of Taiwan-based backlit unit (BLU) maker Coretronic, will likely see a significant increase in drone orders from ODMs and the military sector from 2023 onward.

Taiwan , Coretronic-intelligent-robotics , Blu , Irc , Oretronic , Isplay-system , Isplays-photonics , Rone , Ct-manufacturing , T-ce , Ilitary

BELLUS Health (TSE:BLU) Hits New 52-Week High at $19.68

BELLUS Health Inc. (TSE:BLU – Get Rating)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as C$19.68 and last traded at C$19.68, with a volume of 28994 shares traded. The stock had previously closed at C$19.50. Analyst Ratings Changes Separately, Lifesci Capital downgraded BELLUS Health from […]

Health-inc , Health-daily , Health-price-performance , Bellus-health-inc , Get-rating , Lifesci-capital , Bellus-health , Tse-blu , Blu , Medical , Stocks

GH Research (NASDAQ:GHRS) and BELLUS Health (NASDAQ:BLU) Financial Review

BELLUS Health (NASDAQ:BLU – Get Rating) and GH Research (NASDAQ:GHRS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Insider and Institutional Ownership 90.1% of BELLUS Health shares […]

Ireland , Canada , Dublin , Bellus-health , Given-gh-research , Gh-research , Health-inc , Health-daily , Get-rating , Nasdaq-blu , Blu

Spruce Biosciences (NASDAQ:SPRB) Trading Up 2.6%

Lifesci Capital cut shares of BELLUS Health (TSE:BLU – Get Rating) from an outperform rating to a market perform rating in a report released on Tuesday, PriceTargets.com reports. BELLUS Health Trading Up 0.2 % Shares of TSE:BLU opened at C$19.57 on Tuesday. BELLUS Health has a 12 month low of C$8.07 and a 12 month […]

Health-trading , Health-daily , Health-inc , Lifesci-capital , Get-rating , Bellus-health , Tse-blu , Blu , Medical , Downgrade ,

BELLUS Health (NASDAQ:BLU) Rating Lowered to Market Perform at Lifesci Capital

Lifesci Capital lowered shares of BELLUS Health (NASDAQ:BLU – Get Rating) from an outperform rating to a market perform rating in a report released on Tuesday morning, Marketbeat.com reports. Several other analysts have also recently weighed in on the company. Evercore ISI cut BELLUS Health to an outperform rating in a report on Tuesday. HC […]

Canada , Nasdaq , Goldman-sachs-group-inc , Royal-bank , Health-inc , Health-company-profile , Perceptive-advisors , Health-stock-performance , Health-daily , Lifesci-capital , Get-rating

BELLUS Health (TSE:BLU) Cut to Market Perform at Lifesci Capital

Lifesci Capital lowered shares of BELLUS Health (TSE:BLU – Get Rating) from an outperform rating to a market perform rating in a report issued on Tuesday morning, PriceTargets.com reports. BELLUS Health Stock Up 0.5 % Shares of TSE BLU opened at C$19.53 on Tuesday. BELLUS Health has a 1 year low of C$8.07 and a […]

Health-stock , Health-inc , Health-daily , Lifesci-capital , Get-rating , Bellus-health , Tse-blu , Blu , Medical , Downgrade ,

Evercore ISI Lowers BELLUS Health (NASDAQ:BLU) to Outperform

Evercore ISI lowered shares of BELLUS Health (NASDAQ:BLU – Get Rating) to an outperform rating in a research report report published on Tuesday morning, The Fly reports. A number of other research analysts have also recently weighed in on the company. HC Wainwright restated a buy rating and issued a $20.00 price target on shares […]

Canada , Tower-research-capital , Great-west-life-assurance-co , Deutsche-bank , Group-plc , Health-daily , Proshare-advisors , Health-company-profile , Health-price-performance , Health-inc , Royal-bank

Q1 2023 EPS Estimates for BELLUS Health Inc. Lifted by Jefferies Financial Group (TSE:BLU)

BELLUS Health Inc. (TSE:BLU – Get Rating) – Analysts at Jefferies Financial Group boosted their Q1 2023 earnings per share estimates for shares of BELLUS Health in a research note issued to investors on Tuesday, April 18th. Jefferies Financial Group analyst S. Jeong now forecasts that the company will post earnings per share of ($0.25) […]

Health-price-performance , Health-inc , Analysts-at-jefferies-financial-group , Health-company-profile , Jefferies-financial-group , Health-daily , Bellus-health-inc , Get-rating , Financial-group , Lifesci-capital , Bellus-health

BELLUS Health (NASDAQ:BLU) Downgraded by Royal Bank of Canada to Sector Perform

BELLUS Health (NASDAQ:BLU – Get Rating) was downgraded by stock analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a report issued on Tuesday, The Fly reports. BLU has been the subject of a number of other research reports. HC Wainwright reiterated a “buy” rating and set a […]

Canada , Health-trading , Tower-research-capital , Health-company-profile , Health-daily , Proshare-advisors , Great-west-life-assurance-co , Bellus-health , Deutsche-bank , Health-inc , Royal-bank

BELLUS Health (NASDAQ:BLU) Sets New 52-Week High at $14.43

BELLUS Health Inc. (NASDAQ:BLU – Get Rating) shares reached a new 52-week high during trading on Tuesday . The stock traded as high as $14.43 and last traded at $14.43, with a volume of 67857446 shares changing hands. The stock had previously closed at $7.26. Analyst Ratings Changes Several equities analysts have issued reports on […]

Canada , Royal-bank , Great-west-life-assurance-co , Tower-research-capital , Group-plc , Nasdaq , Health-stock , Health-company-profile , Health-inc , Health-daily , Proshare-advisors